
Renal Cell Carcinoma


November 22, 2023
Adjuvant Everolimus Improves Recurrence-Free Survival in Very High–Risk Renal Cell Carcinoma
The ASCO Post


January 02, 2025
FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection
The ASCO Post

Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.


June 05, 2023
Study Sends Strong Signal Not to Sequence Immune Checkpoint Inhibitors in Advanced Kidney Cancer
Dana-Farber


June 23, 2023
In Case You Missed It: Brief Highlights From Studies Presented During AACR 2023
The ASCO Post
Advertisement
Recommendations
Advertisement